Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PCRHY | CL |
|---|---|---|
| Price | $30.05 | $86.19 |
| Change today | ▲ 1.69% | ▲ 2.29% |
| Market cap | $69.00B | $68.71B |
| Return, 3 months | +12.3% | -8.8% |
| Return, year to date | +132.2% | +11.1% |
| Return, 1 year | +158.8% | +14.1% |
| P/E (TTM) | 55.6 | 33.9 |
| P/B | 2.0 | 291.2 |
| P/E percentile vs own 5y | – | 70th |
| Dividend yield | 0.85% | 2.42% |
| Revenue growth (YoY, latest qtr) | – | +4.9% |
| Net profit growth (YoY) | – | -7.0% |
| Gross margin | – | 60.4% |
| Operating margin | – | 19.3% |
| Net margin | – | 9.7% |
| Return on equity | – | 434.5% |
| Analyst target vs. price | – | +19.0% |
| Analyst buy share | – | 89% |
| RSI (14) | 64 | 45 |
| 30-day volatility | 30.0% | 15.6% |
| Max drawdown, 1 year | -24.9% | -17.0% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
